Perivascular smooth muscle -actin is reduced in the endometrium of women with progestin-only contraceptive breakthrough bleeding
article
OA: closed
CC0
⤵ 18 in-corpus citations
AI-generated summary
Endometrial perivascular alpha-actin is reduced in women using progestin-only contraceptives experiencing breakthrough bleeding compared to those without bleeding issues.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
It has been shown that the endometrium of women using progestin-only contraceptives has increased vascular fragility, although the structural basis for this weakness is unknown, as is its role in breakthrough bleeding (BTB). Perivascular cells such as pericytes and vascular smooth muscle cells surround capillaries during the maturation process following angiogenesis, and act to strengthen and stabilize the vessels. The aim of the present study was to quantify endometrial perivascular smooth muscle alpha-actin (alphaSMA) expression in women using Norplant with and without BTB problems, and compare it to controls. Using immunohistochemical techniques, vessels were classified as level 0, 1 or 2 depending on whether perivascular alphaSMA was absent, discontinuous or continuous. In 15 controls the subepithelial plexus had significantly more level 0 vessels than either the functionalis or basalis (61 +/- 4 versus 31 +/- 6 and 37 +/- 4%, P = 0.0006 and P = 0.0007 respectively). In contrast the functionalis and basalis had significantly more level 2 vessels than the subepithelial plexus (20 +/- 3 and 23 +/- 2 compared to 4 +/- 1%, P = 0.0005 and P = 0.000 respectively). The major finding of the study was that in Norplant users, where the relatively atrophic endometrium cannot be divided into different regions, women with BTB problems (n = 20) had significantly more level 0 vessels than those with reduced bleeding (n = 17) (60 +/- 4 versus 46 +/- 4%, P = 0.0302). Norplant users with BTB problems also had a non-significant reduction in level 2 vessels compared to women without bleeding problems (4 +/- 2 versus 11 +/- 4%, P = 0.0667). These results demonstrate that perivascular alphaSMA is reduced around the endometrial vessels of Norplant users with BTB compared to those with no bleeding problems, and strongly support the concept that reduced vascular structural integrity plays a key role in endometrial BTB.
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (17)
- Dating the Endometrial Biopsy via openalex
- The effects of levonorgestrel implants on vascular endothelial growth factor expression in the endometrium via openalex
- Vascular smooth muscle cell proliferation in arterioles of the human endometrium via openalex
- W2000537146 via openalex
- W2016400776 via openalex
- W2032632614 via openalex
- W2042427065 via openalex
- W2051487747 via openalex
- W2066888615 via openalex
- W2078348571 via openalex
- W2132366506 via openalex
- W2152215024 via openalex
- W2162739993 via openalex
- W62872458 via openalex
- W2262444131 via openalex
- W1566059459 via openalex
- W1975917043 via openalex
Cited by (18)
- Endometriosis-Derived Stromal Cells Secrete Thrombin and Thromboxane A2, Inducing Platelet Activation 2016
- Low pericyte coverage of endometrial microvessels in heavy menstrual bleeding correlates with the microvessel expression of VEGF-A 2014
- Effect of dienogest administration on angiogenesis and hemodynamics in a rat endometrial autograft model 2010
- Best Practice & Research Clinical Obstetrics and Gynaecology 2009
- Abnormal bleeding in postmenopausal hormone users—What do we know today? 2009
- Bleeding with menopausal hormone therapy 2008
- Estrogen Is Not Essential for Full Endometrial Restoration after Breakdown: Lessons from a Mouse Model 2007
- Wall discontinuities and increased expression of vascular endothelial growth factor-A and vascular endothelial growth factor receptors 1 and 2 in endometrial blood vessels of women with menorrhagia 2007
- Influence of different hormonal regimens on endometrial microvascular density and VEGF expression in women suffering from breakthrough bleeding 2005
- Subendometrial and intraendometrial blood flow during the menstrual cycle in patients with endometriosis 2005
- Influence of different hormonal regimens on endometrial microvascular density and VEGF expression in women suffering from breakthrough bleeding 2005
- Changes in endometrial blood vessels in the endometrium of women with hormone replacement therapy-related irregular bleeding 2003
- Human uterine vascular structures in normal and diseased states 2003
- Surface vascularization and endometrial appearance in women with menorrhagia or using levonorgestrel contraceptive implants. Implications for the mechanisms of breakthrough bleeding 2002
- Hormone replacement therapy and irregular bleeding 2001
- Disturbances of endometrial bleeding with hormone replacement therapy 2000
- A functional model for progestogen-induced breakthrough bleeding 2000
- Steroids and endometrial breakthrough bleeding: future directions for research 2000
Source provenance
- openalex
- last seen: 2026-06-04T00:00:01.174412+00:00
License: CC0
· commercial use OK